This document outlines the rules and regulations for conducting clinical trials and importing or manufacturing new drugs in India. It discusses the various forms and permissions required, including Form 44 for new drug approval and Form 12 for importing study drugs. It also describes the responsibilities of sponsors, investigators, and ethics committees. The document explains the different phases of clinical trials from human pharmacology to post-marketing surveillance. It lists the data that must be submitted with applications and included in clinical study reports.